CWD IPO vs Nidan Laboratories IPO

Comparison between CWD IPO and Nidan Laboratories IPO.

IPO Details

CWD IPO is a SME Fixed Price IPO proposed to list at BSE SME while Nidan Laboratories IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of CWD IPO is up to ₹17.11 Cr whereas the issue size of the Nidan Laboratories IPO is up to ₹47.50 Cr. The final issue price of CWD IPO is ₹180.00 per share and of Nidan Laboratories IPO is ₹125.00 per share.

 CWD IPONidan Laboratories IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹180.00 per share₹125.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size800 shares1000 shares
Fresh Issue Size8,00,400 shares38,00,000 shares
Fresh Issue Size (Amount)up to ₹14.41 Crup to ₹47.50 Cr
OFS Issue Size1,50,000 shares0 shares
OFS Issue Size (Amount)up to ₹2.70 Crup to ₹0.00 Cr
Issue Size Total9,50,400 shares38,00,000 shares
Issue Size Total (Amount)up to ₹17.11 Crup to ₹47.50 Cr

IPO Timetable

CWD IPO opens on Sep 30, 2021, while Nidan Laboratories IPO opens on Oct 28, 2021. The closing date of CWD IPO and Nidan Laboratories IPO is Oct 05, 2021, and Nov 02, 2021, respectively.

 CWD IPONidan Laboratories IPO
Issue OpenSep 30, 2021Oct 28, 2021
Issue CloseOct 05, 2021Nov 02, 2021
Basis Of Allotment (Tentative)Oct 08, 2021Nov 09, 2021
Initiation of Refunds (Tentative)Oct 11, 2021Nov 10, 2021
Credit of Share (Tentative)Oct 12, 2021Nov 11, 2021
Listing date (Tentative)Oct 13, 2021Nov 12, 2021

Financials & KPIs

CWD IPO P/E ratio is , as compared to Nidan Laboratories IPO P/E ratio of .

 CWD IPONidan Laboratories IPO
Financials

Company Financials (Restated Standalone)

Period Ended31 Mar 202131 Mar 202031 Mar 2019
Assets6.783.880.59
Total Income2.472.360.04
Profit After Tax1.130.26-0.53
NET Worth1.06-2.51-3.10
Reserves and Surplus-1.70-2.84-3.11
Total Borrowing4.325.703.54
Amount in ₹ Crore

Company Financials (Restated)

Period Ended30 Jun 202131 Mar 202131 Mar 202031 Mar 2019
Assets54.3352.4445.2143.06
Total Income7.8521.8522.1920.97
Profit After Tax1.092.300.710.22
NET Worth14.4213.3311.0310.31
Total Borrowing37.0936.5034.3532.17
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100.00%99.99%
Promoter Shareholding (Post-Issue)72.29%71.22%
Market Cap₹65.01 Cr.₹173.75 Cr.

Shares Offered

In the CWD IPO Retail Individual Investors (RII) are offered 4,75,200 shares while in Nidan Laboratories IPO retail investors are offered 4,75,200 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in CWD IPO and in Nidan Laboratories IPO.

 CWD IPONidan Laboratories IPO
Anchor Investor Reservation0 shares
Market Maker Reservation50,400 shares2,00,000 shares
QIB0 shares
NII4,75,200 shares19,00,000 shares
RII4,75,200 shares19,00,000 shares
Employee0 shares
Total9,50,400 shares38,00,000 shares

Bids Received (Subscription)

CWD IPO subscribed 1.31x in total, whereas Nidan Laboratories IPO subscribed 1.80x.

 CWD IPONidan Laboratories IPO
NII (times)1.91x0.15x
RII (times)0.71x3.44x
Total (times)1.31x1.80x

Compare with others

Compare: